Andén NE, Rubenson A, Fuxe K, Hökfelt T (1967) Evidence for dopamine receptor stimulation by apomorphine. J Pharm Pharmacol 19:627–629
Google Scholar
Borbély AA, Wirz-Justice A (1982) Sleep, sleep depreviation and depression: a hypothesis derived from a model of sleep regulation. Human Neurobiol 1:205–210
Google Scholar
Borbély AA, Tobler I, Hanagasioglu M (1985) Effect of sleep deprivation on sleep and EEG power spectra in the rat. Behav Brain Res 14:171–182
Google Scholar
Braestrup C, Scheel-Krüger J (1976) Methylphenidate-like effects of the new antidepressant drug nomifensine (HOE 1984). Eur J Pharmacol 38:305–312
Google Scholar
Bruinik A, Lichtensteiger W, Schlumpf M (1983) Ontogeny of diurnal rhythms of central dopamine, serotonine and spirodecanone binding sites and of motor activity in the rat. Life Sci 33:31–38
Google Scholar
Carlsson A (1975) Receptor-mediated control of dopamine metabolism. In: Usdin E, Bunney WE Jr (eds) Pre- and postsynaptic receptors. Marcel Dekker, New York, pp 49–65
Google Scholar
Carlsson A, Lindquist M (1978) Effects of antidepressant agents on the synthesis of brain monoamines. J Neural Transm 43:73–91
Google Scholar
Costall B, Kelly DM, Naylor RJ (1975) Nomifensine: a potent dopaminergic agonist of antiparkinson potential. Psychopharmacologia (Berl) 41:153–164
Google Scholar
Di Chiara G, Porceddu ML, Vargiu L, Argiolas A, Gessa GL (1976) Evidence for dopamine receptors mediating sedation in the mouse brain. Nature 264:564–566
Google Scholar
Gessa GL, Porceddu ML, Collu M, Mereu G, Serra M, Onigi E, Biggio G (1985) Sedation and sleep induced by high doses of apomorphine after blockade of D-1 receptors by SCH 23390. Eur J Pharmacol 109:269–274
Google Scholar
Gillin JC, Sitaram N, Mendelsohn WB (1982) Acetylcholine, sleep and depression. Human Neurobiol 1:211–219
Google Scholar
Hanks GW (1977) A profile of nomifensine. Br J Clin Pharmacol 4:243S-248S
Google Scholar
Hoffman I (1977) A comparative review of the pharmacology of nomifensine. Br J Clin Pharmacol 4:69S-75S
Google Scholar
Hunt P, Kannengiesser MH, Raynaud JP (1974) Nomifensine: a new potent inhibitor of dopamine uptake into synaptosomes from rat brain corpus striatum. J Pharm Pharmacol 26:370–371
Google Scholar
Kafi S, Gaillard JM (1976) Brain dopamine receptors and sleep in the rat: effects of stimulation and blockade. Eur J Pharmacol 38:357–363
Google Scholar
Kafka MS, Wirz-Justice A, Naber D (1981) Circadian and seasonal rhythms in α and β-adrenergic receptors in the rat brain. Brain Res 20:409–419
Google Scholar
Koella WP (1985) Neurotransmitters and sleep — a synthesis. In: Koella WP, Rüther E, Schulz H (eds) Sleep '84. Fischer, Stuttgart New York, pp 28–39
Google Scholar
Kovacevic R, Radulovacki M (1976) Monoamine changes in the brain of cats during slow-wave sleep. Science 193:1025–1027
Google Scholar
Lemmer B, Berger T (1978) Diurnal rhythm in the central dopamine turnover in the rat. Naunyn-Schmiedeberg's Arch Pharmacol 38:357–363
Google Scholar
Loew DM, Spiegel R (1976) Polygraphic sleep studies in rats and humans. Arzneimittel-Forsch (Drug Res) 26:1032–1035
Google Scholar
Maj J, Klimek V, Nowak G (1985) Antidepressant drugs given repeatedly increase binding to α1-adrenoceptors in the rat cortex. Eur J Pharmacol 119:113–116
Google Scholar
Mereu GP, Scarbati E, Paglietti E, Pellegrini Quarantotti B, Chessa P, Di Chiara G, Gessa GL (1979) Sleep induced by low doses of apomorphine in rats. Electroenceph Clin Neurophysiol 46:214–219
Google Scholar
Mogilnicka E, Wedzony K, Klimek V, Nowak G (1985) The importance of timing for the action of α1- or β-agonists: possible relationship with the density of [3H]prazosin and [3H]-dihydroalprenolol bindig sites. Eur J Pharmacol 113:279–282
Google Scholar
Nagayama H, Takagi A, Nakamura E, Yoshida H, Takahashi R (1978) Circadian susceptibility rhythm to apomorphine in the brain. Comm Psychopharmacol 2:301–310
Google Scholar
Nagayama H, Takagi A, Sakurai Y, Yoshimoto S, Nishiwaki K, Takahashi R (1979) Chronopharmacological study of neuroleptics. III. Circadian rhythm of brain susceptibility to haloperidol. Psychopharmacology 63:131–135
Google Scholar
Nicholson AN, Pascoe PA, Stone BM (1986) Modulation of catecholamine transmission and sleep in man. Neuropharmacology 25:271–274
Google Scholar
Obál F Jr, Benedek G, Lelkes Z, Obál F (1985) Effects of acute and chronic treatment with amitriptyline on sleep-wake activity in rats. Neuropharmacology 24:223–229
Google Scholar
Okuyama S, Hashimoto S, Aihara H (1985) Effects on the caudate spindle in rats of dopamine microinjected into the caudate nucleus. Neurosci Lett 59:27–32
Google Scholar
Perlow MJ, Gordon EK, Ebert ME, Hoffman HJ, Chase TN (1977) The circadian variation in dopamine metabolism in the subhuman primate. J Neurochem 28:1381–1383
Google Scholar
Racagni G, Mochetti I., Renna G, Guomo V (1982) In vivo studies on central noradrenergic synaptic mechanisms after acute and chronic antidepressant drug treatment: biochemical and behavioral comparison. J Pharmacol Exp Ther 223:227–234
Google Scholar
Radulovacki M, Brodie M, Walovitch R, Yanik G (1981) Bromocriptine, dihydroergotoxine and sleep in rats: effects of repeated administration. Gerontology 27:152–157
Google Scholar
Roth RH (1979) Dopamine autoreceptors: pharmacology, function and comparison with post-synaptic dopamine receptors. Comm Psychorpharmacol 3:429–445
Google Scholar
Schacht U, Leven M, Gerhards HJ, Hunt P, Raynaud JP (1982) Recent investigations on the mechanism of action of nomifensine. Int Pharmacopsychiatr 17:(suppl 1) 21–34
Google Scholar
Scherschlicht R, Polc P, Schneeberger J, Steiner M, Haefely W (1982) Selective suppression of rapid eye movement sleep (REMS) in cats by typical and atypical antidepressants. In: Costa E, Racagni G (eds) Typical and atypical antidepressants: molecular mechanisms. Raven Press, New York, pp 359–364
Google Scholar
Schulz H, Lund R (1985) On the origin of early REM episodes in sleep of depressed patients: a comparison of three hypothesis. Psychiatry Res 16:65–77
Google Scholar
Strömbom U (1976) Catecholamine receptor agonists. Effects on motor activity and rate of tyrosine hydroxylation in mouse brain. Naunyn-Schmiedeberg's Arch Pharmacol 24:744–747
Google Scholar
Svensson TH (1984) Central α-adrenoceptors and the mechanisms of action of antidepressant drugs. Adv Biochem Psychopharmacol 39:241–248
Google Scholar
Wauquier A (1985) Dopamine: its active and permissive roles in sleep-wakefulness. In: Koella WP, Rather E, Schulz H (eds) Sleep `84. Fischer, Stuttgart New York, pp 14–16
Google Scholar
Watanabe S, Seeman P (1984) D2 dopamine receptor density in rat striatum over 24 hours: lack of detectable changes. Biol Psychiatr 19:1249–1253
Google Scholar
Wher TA, Wirz-Justice A, Goodwin FK (1979) Phase advance of the circadian sleep-wake cycle as an antidepressant. Science 206:710–713
Google Scholar
Wolfe GW, Bousquet WF, Schnell RC (1977) Circadian variations in responses to amphetamine and chlorpromazine in the rat. Comm Psychopharmacol 1:29–37
Google Scholar